ATE196288T1 - N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren - Google Patents
N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitorenInfo
- Publication number
- ATE196288T1 ATE196288T1 AT95921534T AT95921534T ATE196288T1 AT E196288 T1 ATE196288 T1 AT E196288T1 AT 95921534 T AT95921534 T AT 95921534T AT 95921534 T AT95921534 T AT 95921534T AT E196288 T1 ATE196288 T1 AT E196288T1
- Authority
- AT
- Austria
- Prior art keywords
- hiv protease
- protease inhibitors
- hydroxybutyl
- amino
- sulfonamide derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
- C07C323/49—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/247,983 US5527829A (en) | 1994-05-23 | 1994-05-23 | HIV protease inhibitors |
PCT/US1995/006866 WO1995032185A1 (en) | 1994-05-23 | 1995-05-23 | N-(3-amino-2-hydroxybutyl)sulphonamide derivatives as hiv protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE196288T1 true ATE196288T1 (de) | 2000-09-15 |
Family
ID=22937168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95921534T ATE196288T1 (de) | 1994-05-23 | 1995-05-23 | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren |
Country Status (12)
Country | Link |
---|---|
US (1) | US5527829A (de) |
EP (1) | EP0763017B1 (de) |
JP (2) | JP3732858B2 (de) |
AT (1) | ATE196288T1 (de) |
AU (1) | AU2658695A (de) |
CA (1) | CA2190472A1 (de) |
DE (1) | DE69518840T2 (de) |
DK (1) | DK0763017T3 (de) |
ES (1) | ES2151600T3 (de) |
GR (1) | GR3035014T3 (de) |
PT (1) | PT763017E (de) |
WO (1) | WO1995032185A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040122000A1 (en) | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
US6878728B1 (en) | 1999-06-11 | 2005-04-12 | Vertex Pharmaceutical Incorporated | Inhibitors of aspartyl protease |
US5484926A (en) | 1993-10-07 | 1996-01-16 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
MY126358A (en) * | 1996-03-22 | 2006-09-29 | Glaxo Group Ltd | Compositions comprising vx478 and a water soluble tocopherol derivative such as vitamin e-tpgs |
US5962725A (en) | 1996-09-05 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Intermediate compounds useful for making HIV protease inhibitors such as nelfinavir |
US5705647A (en) * | 1996-09-05 | 1998-01-06 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
US5925759A (en) | 1996-09-05 | 1999-07-20 | Agouron Pharmaceuticals, Inc. | Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors |
US6001851A (en) * | 1997-03-13 | 1999-12-14 | Agouron Pharmaceuticals, Inc. | HIV protease inhibitors |
DE19730602A1 (de) * | 1997-07-17 | 1999-01-21 | Clariant Gmbh | 3-Acetoxy-2-methylbenzoesäurechlorid und ein Verfahren zu seiner Herstellung |
US6084107A (en) * | 1997-09-05 | 2000-07-04 | Agouron Pharmaceuticals, Inc. | Intermediates for making HIV-protease inhibitors |
US6436989B1 (en) | 1997-12-24 | 2002-08-20 | Vertex Pharmaceuticals, Incorporated | Prodrugs of aspartyl protease inhibitors |
ATE285396T1 (de) | 1998-06-19 | 2005-01-15 | Vertex Pharma | Sulfonamide als aspartyl-protease-inhibitoren |
TNSN00027A1 (fr) | 1999-02-12 | 2005-11-10 | Vertex Pharma | Inhibiteurs de l'aspartyle protease |
US6403799B1 (en) | 1999-10-21 | 2002-06-11 | Agouron Pharmaceuticals, Inc. | Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors |
US6506786B2 (en) | 2001-02-13 | 2003-01-14 | Pharmacor Inc. | HIV protease inhibitors based on amino acid derivatives |
DE10226219A1 (de) * | 2002-06-13 | 2004-01-08 | Bayer Ag | Verfahren zur Herstellung von 3-Acyloxy-2-methylbenzoesäuren |
US7388008B2 (en) * | 2004-08-02 | 2008-06-17 | Ambrilia Biopharma Inc. | Lysine based compounds |
CA2606025A1 (en) * | 2005-04-27 | 2006-11-02 | Ambrilia Biopharma Inc. | Method for improving pharmacokinetics of protease inhibitors and protease inhibitor precursors |
AU2006319716B2 (en) * | 2005-11-30 | 2012-02-02 | Taimed Biologics, Inc. | Lysine-based prodrugs of aspartyl protease inhibitors and processes for their preparation |
US8410300B2 (en) * | 2006-09-21 | 2013-04-02 | Taimed Biologics, Inc. | Protease inhibitors |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5142056A (en) * | 1989-05-23 | 1992-08-25 | Abbott Laboratories | Retroviral protease inhibiting compounds |
DE3023855A1 (de) * | 1980-06-25 | 1982-01-14 | Bayer Ag, 5090 Leverkusen | Reaktivfarbstoffe, verfahren zu ihrer herstellung und ihre verwendung zum faerben und bedrucken hydroxylgruppenhaltiger oder stickstoffhaltiger fasermaterialien |
IL89900A0 (en) * | 1988-04-12 | 1989-12-15 | Merck & Co Inc | Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them |
CA1340588C (en) * | 1988-06-13 | 1999-06-08 | Balraj Krishan Handa | Amino acid derivatives |
IL91307A0 (en) * | 1988-08-24 | 1990-03-19 | Merck & Co Inc | Hiv protease inhibitors and pharmaceutical compositions for the treatment of aids containing them |
EP0361341A3 (de) * | 1988-09-28 | 1991-07-03 | Miles Inc. | Therapeutika für AIDS auf der Basis von HIV-Protease-Inhibitoren |
US5063208A (en) * | 1989-07-26 | 1991-11-05 | Abbott Laboratories | Peptidyl aminodiol renin inhibitors |
WO1991008221A1 (en) * | 1989-12-04 | 1991-06-13 | Wisconsin Alumni Research Foundation | Peptide inhibitors of hiv protease |
GB8927913D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Amino acid derivatives |
GB8927915D0 (en) * | 1989-12-11 | 1990-02-14 | Hoffmann La Roche | Novel alcohols |
CA2056911C (en) * | 1990-12-11 | 1998-09-22 | Yuuichi Nagano | Hiv protease inhibitors |
AU647239B2 (en) * | 1991-02-08 | 1994-03-17 | Sankyo Company Limited | New beta-amino- alpha-hydroxycarboxylic acids and their use |
US5235039A (en) * | 1991-06-10 | 1993-08-10 | Eli Lilly And Company | Substrates for hiv protease |
CN1071930A (zh) * | 1991-07-10 | 1993-05-12 | 伊莱利利公司 | 用作治疗艾滋病的人免疫缺陷病毒蛋白酶的抑制剂 |
DE4126482A1 (de) * | 1991-08-10 | 1993-02-11 | Bayer Ag | (alpha)-trifluormethyl-substituierte, gesaettigt-bicyclische amine und verfahren zu deren herstellung |
US5516784A (en) * | 1991-08-13 | 1996-05-14 | Schering Corporation | Anti-HIV (AIDS) agents |
EP0534511A1 (de) * | 1991-08-16 | 1993-03-31 | Merck & Co. Inc. | HIV-Protease-Hemmer zur Behandlung von AIDS |
US5256783A (en) * | 1991-09-18 | 1993-10-26 | Hoffmann-La Roche Inc. | Method for producing 2-isoquinoline compounds |
WO1993008184A1 (en) * | 1991-10-23 | 1993-04-29 | Merck & Co., Inc. | Hiv protease inhibitors |
ZA929869B (en) * | 1991-12-20 | 1994-06-20 | Syntex Inc | Hiv protease inhibitors |
DK0560268T3 (da) * | 1992-03-13 | 1995-06-12 | Bio Mega Boehringer Ingelheim | Substituerede pipecolinsyrederivater som HIV-proteasehæmmere |
EP0957093A3 (de) * | 1992-05-21 | 2000-04-12 | Monsanto Company | Retrovirusprotease Inhibitoren |
WO1994004491A1 (en) * | 1992-08-25 | 1994-03-03 | G.D. Searle & Co. | N-(alkanoylamino-2-hydroxypropyl)-sulfonamides useful as retroviral protease inhibitors |
EP0810209B1 (de) * | 1992-08-25 | 2002-06-05 | G.D. Searle & Co. | Hydroxyethylaminosulfonamide verwendbar als Inhibitoren retroviraler Proteasen |
IS2334B (is) * | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
-
1994
- 1994-05-23 US US08/247,983 patent/US5527829A/en not_active Expired - Fee Related
-
1995
- 1995-05-23 ES ES95921534T patent/ES2151600T3/es not_active Expired - Lifetime
- 1995-05-23 DK DK95921534T patent/DK0763017T3/da active
- 1995-05-23 DE DE69518840T patent/DE69518840T2/de not_active Expired - Fee Related
- 1995-05-23 PT PT95921534T patent/PT763017E/pt unknown
- 1995-05-23 AU AU26586/95A patent/AU2658695A/en not_active Abandoned
- 1995-05-23 JP JP53056295A patent/JP3732858B2/ja not_active Expired - Fee Related
- 1995-05-23 CA CA002190472A patent/CA2190472A1/en not_active Abandoned
- 1995-05-23 WO PCT/US1995/006866 patent/WO1995032185A1/en active IP Right Grant
- 1995-05-23 EP EP95921534A patent/EP0763017B1/de not_active Expired - Lifetime
- 1995-05-23 AT AT95921534T patent/ATE196288T1/de not_active IP Right Cessation
-
2000
- 2000-12-06 GR GR20000402705T patent/GR3035014T3/el not_active IP Right Cessation
-
2005
- 2005-07-26 JP JP2005216300A patent/JP2006022106A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US5527829A (en) | 1996-06-18 |
EP0763017A1 (de) | 1997-03-19 |
DE69518840D1 (en) | 2000-10-19 |
GR3035014T3 (en) | 2001-03-30 |
AU2658695A (en) | 1995-12-18 |
WO1995032185A1 (en) | 1995-11-30 |
JP3732858B2 (ja) | 2006-01-11 |
JP2006022106A (ja) | 2006-01-26 |
PT763017E (pt) | 2001-01-31 |
DE69518840T2 (de) | 2001-01-11 |
JPH10501796A (ja) | 1998-02-17 |
ES2151600T3 (es) | 2001-01-01 |
CA2190472A1 (en) | 1995-11-30 |
DK0763017T3 (da) | 2001-01-08 |
EP0763017B1 (de) | 2000-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY138860A (en) | Hiv protease inhibitors. | |
DE69518840T2 (de) | N-(3-amino-2-hydroxybutyl)sulfonamid-derivate as hiv-protease-inhibitoren | |
EA199800943A1 (ru) | Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы | |
MX9603909A (es) | Derivados de sulfonamida como inhibidores de proteasa aspartilo. | |
BR0009485A (pt) | Método e composições para evitar ou reduzir infecção por hiv pelo uso de inibidores para leucina aminopeptidase | |
FI962022A0 (fi) | 5,6-dihydropyronijohdannaiset proteaasi-inhibiittoreina ja antiviraalisina aineina | |
ES2176263T3 (es) | 5,6-dihidropironas derivadas como inhibidores de proteasa y agentes antivirus. | |
ATE179164T1 (de) | Hiv-proteaseinhibitoren | |
ATE286395T1 (de) | Antithrombotische mittel | |
MY117535A (en) | Hiv protease inhibitors | |
IT1318424B1 (it) | Composti con attivita' anti-hiv. | |
EE9900188A (et) | HIV proteaasi inhibiitoritena kasulikud 1-(3-aminoindasool-5-üül)-3-fenüülmetüül-tsüklilised uuread | |
TH14264B (th) | ตัวยับยั้ง hiv โพรทิเอส |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee |